ADMA Biologics (ADMA) Short Interest Ratio & Short Volume → It's time to ween off Chinese lithium! (From Smallcaps Daily) (Ad) Free ADMA Stock Alerts $10.36 -0.11 (-1.05%) (As of 02:13 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ADMA Biologics Short Interest DataCurrent Short Interest8,440,000 sharesPrevious Short Interest8,720,000 sharesChange Vs. Previous Month-3.21%Dollar Volume Sold Short$76.80 millionShort Interest Ratio2.9 Days to CoverLast Record DateMay 15, 2024Outstanding Shares231,810,000 sharesPercentage of Shares Shorted3.64%Today's Trading Volume1,425,146 sharesAverage Trading Volume2,756,655 sharesToday's Volume Vs. Average52% Short Selling ADMA Biologics ? Sign up to receive the latest short interest report for ADMA Biologics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartADMA Short Interest Over TimeADMA Days to Cover Over TimeADMA Percentage of Float Shorted Over Time Ad DeFi Distribution[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially profit from this trillion-dollar niche WITHOUT buying a single coin, NFT or investing in ANYTHING.Grab the PDF here for free: ADMA Biologics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20248,440,000 shares $76.80 million -3.2%N/A2.9 $9.10 4/30/20248,720,000 shares $56.85 million +7.5%N/A3.4 $6.52 4/15/20248,110,000 shares $48.50 million +11.3%N/A3.2 $5.98 3/31/20247,290,000 shares $48.11 million -8.8%N/A2.7 $6.60 3/15/20247,990,000 shares $47.86 million +18.9%N/A3 $5.99 2/29/20246,720,000 shares $36.02 million +9.3%N/A2.6 $5.36 Get the Latest News and Ratings for ADMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ADMA Biologics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20246,150,000 shares $33.21 million -10.1%N/A2.9 $5.40 1/31/20246,840,000 shares $35.50 million -14.8%N/A3.2 $5.19 1/15/20248,030,000 shares $40.07 million +19.0%N/A3.7 $4.99 12/31/20236,750,000 shares $30.51 million -13.6%N/A3.4 $4.52 12/15/20237,810,000 shares $32.80 million -10.2%N/A4.2 $4.20 11/30/20238,700,000 shares $32.19 million -6.3%N/A4.9 $3.70 11/15/20239,280,000 shares $35.26 million -3.1%N/A4.8 $3.80 10/31/20239,580,000 shares $32.38 million +3.9%N/A4.1 $3.38 10/15/20239,220,000 shares $29.60 million +3.3%N/A4.2 $3.21 9/30/20238,930,000 shares $31.97 million +2.8%N/A4.1 $3.58 9/15/20238,690,000 shares $32.41 million -1.9%N/A4.1 $3.73 8/31/20238,860,000 shares $34.11 million -1.7%N/A4 $3.85 8/15/20239,010,000 shares $40.91 million +8.4%N/A4.2 $4.54 7/31/20238,310,000 shares $34.49 million -2.4%N/A4.1 $4.15 7/15/20238,510,000 shares $30.38 million +2.7%N/A4.2 $3.57 6/30/20238,290,000 shares $30.59 million -19.8%N/A3.9 $3.69 6/15/202310,340,000 shares $41.26 million -1.2%N/A4.6 $3.99 5/31/202310,460,000 shares $42.57 million -6.4%N/A4.4 $4.07 5/15/202311,170,000 shares $46.80 million -1.2%N/A4.6 $4.19 4/30/202311,310,000 shares $37.89 million -2.8%N/A5.1 $3.35 4/15/202311,640,000 shares $37.02 million -6.8%N/A4.9 $3.18 3/31/202312,490,000 shares $41.34 million +14.4%N/A5.1 $3.31 3/15/202310,920,000 shares $34.18 million +0.8%N/A4.4 $3.13 2/28/202310,830,000 shares $38.45 million -6.2%N/A3.8 $3.55 2/15/202311,550,000 shares $41.35 million -9.7%N/A3.9 $3.58 1/31/202312,790,000 shares $47.20 million +6.1%N/A3.8 $3.69 1/15/202312,050,000 shares $40.97 million -5.3%N/A3.7 $3.40 12/30/202212,720,000 shares $49.35 million +1.8%N/A4 $3.88 12/15/202212,500,000 shares $44.50 million -37.4%N/A3.7 $3.56 11/30/202219,980,000 shares $66.73 million -8.1%N/A6 $3.34 11/15/202221,740,000 shares $70.44 million -15.9%N/A7.2 $3.24 10/31/202225,860,000 shares $72.93 million +0.2%N/A9.1 $2.82 10/15/202225,820,000 shares $67.65 million -6.3%N/A9.5 $2.62 9/30/202227,560,000 shares $66.97 million +6.0%N/A10.4 $2.43It's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution 9/15/202225,990,000 shares $70.43 million -2.0%N/A9 $2.71 8/31/202226,520,000 shares $71.60 million -6.2%N/A9.8 $2.70 8/15/202228,270,000 shares $68.13 million -1.7%N/A10.7 $2.41 7/31/202228,760,000 shares $61.55 million +0.1%N/A11.1 $2.14 7/15/202228,730,000 shares $66.08 million +1.3%N/A10.2 $2.30 6/30/202228,360,000 shares $56.15 million +11.0%N/A9.8 $1.98 6/15/202225,540,000 shares $51.85 million +1.0%N/A8.1 $2.03 5/31/202225,300,000 shares $51.87 million +5.4%N/A9.3 $2.05 5/15/202224,010,000 shares $42.26 million +4.5%N/A9.2 $1.76 4/30/202222,980,000 shares $42.28 million +3.1%N/A9.1 $1.84 4/15/202222,300,000 shares $44.82 million +10.1%N/A9.3 $2.01 3/31/202220,250,000 shares $37.06 million +25.0%N/A8.8 $1.83 3/15/202216,200,000 shares $25.11 million +10.7%N/A8.2 $1.55 2/28/202214,640,000 shares $23.57 million +4.4%N/A7.4 $1.61 2/15/202214,020,000 shares $23.41 million +36.0%N/A7.2 $1.67 1/31/202210,310,000 shares $14.95 million +1.2%N/A4.6 $1.45 1/15/202210,190,000 shares $14.27 million -4.1%N/A4.5 $1.40 12/31/202110,620,000 shares $14.97 million +6.6%N/A4.1 $1.41 12/15/20219,960,000 shares $12.75 million -1.2%N/A4 $1.28 11/30/202110,080,000 shares $13.91 million -9.7%N/A4.1 $1.38 11/15/202111,160,000 shares $17.30 million -7.4%N/A3.5 $1.55 10/29/202112,050,000 shares $15.54 million +4.4%N/A3.5 $1.29 10/15/202111,540,000 shares $12.69 million +10.5%N/A3.5 $1.10 9/30/202110,440,000 shares $11.80 million -9.9%8.3%3.6 $1.13 9/15/202111,590,000 shares $13.91 million -5.2%9.2%3.7 $1.20 8/31/202112,220,000 shares $16.37 million -3.3%9.7%3.9 $1.34 8/13/202112,640,000 shares $18.83 million -5.1%10.0%4.9 $1.49 7/30/202113,320,000 shares $20.65 million +14.2%10.6%6.3 $1.55 7/15/202111,660,000 shares $17.26 million +14.8%9.2%1.8 $1.48 6/30/202110,160,000 shares $16.26 million -16.9%8.1%1.5 $1.60 6/15/202112,220,000 shares $21.75 million +11.4%9.7%1.8 $1.78 5/28/202110,970,000 shares $19.20 million -0.6%8.7%1.6 $1.75 5/14/202111,040,000 shares $17.88 million -21.4%N/A1.6 $1.62 4/30/202114,050,000 shares $28.80 million +36.0%N/A1.9 $2.05 4/15/202110,330,000 shares $17.77 million +2.6%N/A2.9 $1.72 3/31/202110,070,000 shares $17.22 million +17.9%N/A2.8 $1.71 3/15/20218,540,000 shares $18.10 million +4.4%N/A2.3 $2.12 2/26/20218,180,000 shares $19.22 million -6.5%N/A2 $2.35 2/12/20218,750,000 shares $25.29 million -9.3%N/A2.2 $2.89 1/29/20219,650,000 shares $20.94 million -13.0%N/A2.6 $2.17 1/15/202111,090,000 shares $23.40 million -4.3%N/A3.4 $2.11 12/31/202011,590,000 shares $23.30 million -3.2%N/A4 $2.01 12/15/202011,970,000 shares $25.38 million +0.2%N/A3.8 $2.12 11/30/202011,950,000 shares $22.71 million -2.3%N/A4.1 $1.90 11/15/202012,230,000 shares $23.48 million -5.4%N/A3.8 $1.92 10/30/202012,930,000 shares $26.25 million -8.3%N/A2.7 $2.03 10/15/202014,100,000 shares $32.29 million +1.4%N/A2.2 $2.29 9/30/202013,910,000 shares $33.24 million +4.1%N/A2.2 $2.39 9/15/202013,360,000 shares $31.26 million +0.4%N/A2.3 $2.34 8/31/202013,310,000 shares $33.94 million +12.0%N/A2.3 $2.55It's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution 8/14/202011,880,000 shares $37.07 million +21.1%N/A2 $3.12 7/31/20209,810,000 shares $35.02 million +1.7%N/A2.3 $3.57 7/15/20209,650,000 shares $27.99 million +0.9%N/A3.5 $2.90 6/30/20209,560,000 shares $28.01 million +3.8%N/A3.6 $2.93 6/15/20209,210,000 shares $28.46 million -7.5%N/A3.3 $3.09 5/29/20209,960,000 shares $32.77 million +2.9%N/A3.2 $3.29 5/15/20209,680,000 shares $25.36 million +10.5%N/A3.3 $2.62 4/30/20208,760,000 shares $25.84 million +2.9%N/A2.9 $2.95 4/15/20208,510,000 shares $23.40 million +17.5%N/A3.2 $2.75 3/31/20207,240,000 shares $22.15 million +4.1%N/A2.9 $3.06 3/13/20206,958,500 shares $19.00 million +29.8%N/A2.4 $2.73 2/28/20205,360,000 shares $16.40 million +11.2%N/A3.5 $3.06 2/14/20204,820,000 shares $12.48 million +3.7%N/A4.1 $2.59 1/31/20204,650,000 shares $14.83 million -10.9%10.3%4.9 $3.19 1/15/20205,220,000 shares $18.74 million -0.8%11.5%7.2 $3.59 12/31/20195,260,000 shares $22.41 million +2.9%11.6%7.3 $4.26 ADMA Short Interest - Frequently Asked Questions What is ADMA Biologics' current short interest? Short interest is the volume of ADMA Biologics shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 8,440,000 shares of ADMA short. Learn More on ADMA Biologics' current short interest. What is a good short interest ratio for ADMA Biologics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADMA shares currently have a short interest ratio of 3.0. Learn More on ADMA Biologics's short interest ratio. Which institutional investors are shorting ADMA Biologics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ADMA Biologics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is ADMA Biologics' short interest increasing or decreasing? ADMA Biologics saw a decline in short interest in May. As of May 15th, there was short interest totaling 8,440,000 shares, a decline of 3.2% from the previous total of 8,720,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ADMA Biologics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to ADMA Biologics: Solid Biosciences Inc. (3.02%), Champions Oncology, Inc. (0.92%), Repligen Co. (8.38%), Vaxcyte, Inc. (8.75%), Exelixis, Inc. (3.77%), Revolution Medicines, Inc. (7.84%), Halozyme Therapeutics, Inc. (6.80%), CRISPR Therapeutics AG (18.05%), Krystal Biotech, Inc. (9.84%), ImmunityBio, Inc. (38.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short ADMA Biologics stock? Short selling ADMA is an investing strategy that aims to generate trading profit from ADMA Biologics as its price is falling. ADMA shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ADMA Biologics? A short squeeze for ADMA Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADMA, which in turn drives the price of the stock up even further. How often is ADMA Biologics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADMA, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: SLDB Short Squeeze CSBR Short Squeeze RGEN Short Squeeze PCVX Short Squeeze EXEL Short Squeeze RVMD Short Squeeze HALO Short Squeeze CRSP Short Squeeze KRYS Short Squeeze IBRX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADMA) was last updated on 6/10/2024 by MarketBeat.com Staff From Our Partners[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...DeFi Distribution | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADMA Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ADMA Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.